X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
TEVA PHARMA
Dec-13
JUBILANT LIFE SCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1872,675-   
Low Rs652,324-   
Sales per share (Unadj.) Rs364.31,535.0-  
Earnings per share (Unadj.) Rs6.895.9-  
Cash flow per share (Unadj.) Rs24.5220.0-  
Dividends per share (Unadj.) Rs3.0083.94-  
Dividend yield (eoy) %2.43.4 70.9%  
Book value per share (Unadj.) Rs164.91,705.1-  
Shares outstanding (eoy) m159.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 21.2%   
Avg P/E ratio x18.426.1 70.6%  
P/CF ratio (eoy) x5.111.4 45.3%  
Price / Book Value ratio x0.81.5 52.1%  
Dividend payout %43.887.5 50.1%   
Avg Mkt Cap Rs m20,0612,119,254 0.9%   
No. of employees `0006.244.9 13.8%   
Total wages/salary Rs m11,0520-   
Avg. sales/employee Rs Th9,383.028,962.5 32.4%   
Avg. wages/employee Rs Th1,786.90-   
Avg. net profit/employee Rs Th176.31,809.3 9.7%   
INCOME DATA
Net Sales Rs m58,0341,301,721 4.5%  
Other income Rs m1910-   
Total revenues Rs m58,2241,301,721 4.5%   
Gross profit Rs m5,786356,477 1.6%  
Depreciation Rs m2,812105,219 2.7%   
Interest Rs m3,23725,568 12.7%   
Profit before tax Rs m-72225,690 -0.0%   
Minority Interest Rs m-2861,025 -27.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-148,153 -1.4%   
Tax Rs m696-2,755 -25.3%   
Profit after tax Rs m1,09081,318 1.3%  
Gross profit margin %10.027.4 36.4%  
Effective tax rate %-965.9-1.2 79,112.4%   
Net profit margin %1.96.2 30.1%  
BALANCE SHEET DATA
Current assets Rs m29,280879,178 3.3%   
Current liabilities Rs m38,912766,717 5.1%   
Net working cap to sales %-16.68.6 -192.1%  
Current ratio x0.81.1 65.6%  
Inventory Days Days8491 92.9%  
Debtors Days Days5196 52.8%  
Net fixed assets Rs m55,712425,171 13.1%   
Share capital Rs m1553,204 4.8%   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,2651,445,965 1.8%   
Long term debt Rs m17,169665,599 2.6%   
Total assets Rs m88,6062,974,850 3.0%  
Interest coverage x1.09.8 9.9%   
Debt to equity ratio x0.70.5 142.0%  
Sales to assets ratio x0.70.4 149.7%   
Return on assets %4.93.6 135.9%  
Return on equity %4.25.6 73.8%  
Return on capital %11.64.9 234.6%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,026207,427 3.9%  
From Investments Rs m-1,744-73,500 2.4%  
From Financial Activity Rs m-4,447-248,823 1.8%  
Net Cashflow Rs m1,834-114,895 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.08 Rs / USD

Compare JUBILANT LIFE SCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare JUBILANT LIFE SCIENCES With: IPCA LABS  DISHMAN PHARMA  ALEMBIC LTD  FULFORD INDIA  NOVARTIS  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views On News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 22, 2017 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS